These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2408269)

  • 21. Homologous human blood protein separation using immobilized metal affinity chromatography: protein C separation from prothrombin with application to the separation of factor IX and prothrombin.
    Wu H; Bruley DF
    Biotechnol Prog; 1999; 15(5):928-31. PubMed ID: 10514264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of rabbit factor IX and its existence as a two-chain factor IX alpha in circulating plasma.
    Rao LV; Hoang AD
    Thromb Res; 1991 Oct; 64(1):57-68. PubMed ID: 1776139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of canine factor IX.
    Sugahara Y; Catalfamo J; Brooks M; Hitomi E; Bajaj SP; Kurachi K
    Thromb Haemost; 1996 Mar; 75(3):450-5. PubMed ID: 8701406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    Bray GL; Weinmann AF; Thompson AR
    J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor IX Kawachinagano: impaired function of the Gla-domain caused by attached propeptide region due to substitution of arginine by glutamine at position -4.
    Sugimoto M; Miyata T; Kawabata S; Yoshioka A; Fukui H; Iwanaga S
    Br J Haematol; 1989 Jun; 72(2):216-21. PubMed ID: 2757966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of conformation-specific affinity purification methods for plasma vitamin K-dependent proteins.
    Yan SB
    J Mol Recognit; 1996; 9(3):211-8. PubMed ID: 8938593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
    Wojcik EG; Van Den Berg M; Poort SR; Bertina RM
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
    Volkov GL; Andrianov SI; Horoshnykova TV; Borysevych OS; Gavryliuk OS
    Ukr Biokhim Zh (1999); 2000; 72(4-5):109-21. PubMed ID: 11200439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of semi-industrial monolithic columns for downstream processing of clotting factor IX.
    Branović K; Buchacher A; Barut M; Strancar A; Josic D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 790(1-2):175-82. PubMed ID: 12767330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anion-exchange purification of recombinant factor IX from cell culture supernatant using different chromatography supports.
    Ribeiro DA; Passos DF; Ferraz HC; Castilho LR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():111-8. PubMed ID: 24076525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.
    Wojcik EG; van den Berg M; van der Linden IK; Poort SR; Cupers R; Bertina RM
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):753-9. PubMed ID: 7487929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of factor IX Chapel Hill: comparison to normal human factor IX.
    Chung KS; Goldsmith JC; Roberts HR
    Bibl Haematol; 1977; 44():68-74. PubMed ID: 617785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals.
    Smith KJ
    Blood; 1988 Oct; 72(4):1269-77. PubMed ID: 3262386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and properties of a therapeutic factor IX concentrate.
    Suomela H; Myllylä G; Raaska E
    Vox Sang; 1977 Jul; 33(1):37-50. PubMed ID: 883244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules.
    Osterud B; Kasper CK; Prodanos C
    Thromb Res; 1979; 15(1-2):235-43. PubMed ID: 483278
    [No Abstract]   [Full Text] [Related]  

  • 39. A simplified procedure for purification of human prothrombin, factor IX and factor X.
    Bajaj SP; Rapaport SI; Prodanos C
    Prep Biochem; 1981; 11(4):397-412. PubMed ID: 7312833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immobilized metal affinity chromatography of monoclonal immunoglobulin M against mutant amidase from Pseudomonas aeruginosa.
    Martins S; Karmali A; Andrade J; Serralheiro ML
    Mol Biotechnol; 2006 Jun; 33(2):103-14. PubMed ID: 16757797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.